Jpmorgan Chase & Co »

Pieris Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Pieris Pharmaceuticals (PIRS) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Pieris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pieris Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pieris Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $435 26 16.74
2024-06-30 $266 27 9.88

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Nvidia Corporation Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Ser 1 S&p Common (SPY)
Meta Platforms Common (META)
Eli Lilly & Co Common (LLY)
Alphabet Common (GOOG)
Unitedhealth Group Common (UNH)
Mastercard Incorporated Common (MA)
Vanguard Index Fds S&p 500 Etf Common (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Vanguard Total Intl Bond Etf Fund (BNDX)
Broadcom Common (AVGO)
Exxon Mobil Corp Common (XOM)

View all positions for Jpmorgan Chase & Co

Top funds holding Pieris Pharmaceuticals

BVF
BML Capital Management
Lynx1 Capital Management
Renaissance Technologies
CM Management
Frazier Life Sciences Management
BlackRock
BlackRock
Geode Capital Management
Citadel Advisors
Vanguard Group
Acadian Asset Management
Citigroup
Tower Research Capital
Group One Trading

View all funds holding Pieris Pharmaceuticals